Cargando…
Immune checkpoint inhibitors in Wilms' tumor and Neuroblastoma: What now?
BACKGROUND: Therapeutic activation of tumor‐infiltrating lymphocytes using monoclonal antibodies targeting PD1 or PD‐L1 (immune checkpoint inhibitors—ICIs) has revolutionized treatment of specific solid tumors in adult cancer patients, and much hope has been placed on a similar effect in relapsed or...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714551/ https://www.ncbi.nlm.nih.gov/pubmed/33932141 http://dx.doi.org/10.1002/cnr2.1397 |